Evidence map›Paper›PMID 40661636›Full record

ArticlebioRxiv : the preprint server for biology2025

Dynamic regulation of origin firing factors links CDK activity to dormant origin activation.

Md Shahadat Hossain, Courtney G Sansam, Kimberlie A Wittig, Tyler D Noble, Kevin A Boyd, Christopher L Sansam

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Md Shahadat HossainDepartment of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104.ORCID 0000-0003-1724-1823
Courtney G SansamCell Cycle and Cancer Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104.ORCID 0000-0002-0253-8643
Kimberlie A WittigDepartment of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104.ORCID 0000-0002-8993-4007
Tyler D NobleDepartment of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104.ORCID 0000-0002-6073-7691
Kevin A BoydCell Cycle and Cancer Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104.ORCID 0000-0001-6739-8103
Christopher L SansamDepartment of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104.ORCID 0000-0002-0545-2693

Funding

Pilot Projects ProgramP30GM149376 · NIGMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI Linda F Thompson · 2023 to 2026
$7.4M
Mechanisms Regulating DNA Replication in the Developing Vertebrate EmbryoR01GM121703 · NIGMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI SANSAM, CHRISTOPHER L · 2017 to 2021
$1.9M
NIGMS NIH HHS P30 GM149376NIGMS NIH HHS R01 GM121703
6 · The paper itself

Abstract

Dormant replication origins help ensure complete genome duplication when replication forks stall, yet how these origins are activated remains poorly understood. Here, we identify a novel regulatory mechanism by which cyclin-dependent kinase (CDK) activity controls the abundance and chromatin recruitment of the origin firing factors TRESLIN and MTBP to promote dormant origin activation. Inhibition of WEE1 kinase during S phase increases CDK activity, which blocks the PCNA-dependent degradation of TRESLIN and enhances its chromatin association along with MTBP. This increased loading is required for elevated helicase recruitment and DNA synthesis under CDK-hyperactive conditions. These effects are reversed by CDK inhibition and depend on both TRESLIN and MTBP. We define a conserved sequence within TRESLIN required for its CDK-sensitive degradation. Significantly, the recruitment of TRESLIN-MTBP and loading of helicase exceed levels observed in unperturbed S phase, supporting a model in which dormant origin firing is actively upregulated through CDKmediated stabilization of the initiation machinery. These findings uncover a new control point in replication origin usage with implications for genome stability and therapeutic kinase inhibition.

Identifiers

PMID40661636
PMCPMC12259077

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.